Theraloc
Active substance: nimotuzumab
nimotuzumab
Centralised EU authorisationActive
Marketing holder: Oncoscience AG
Verified 2026-10-09 · EMA
- Source: EMA
- Countries with the substance registered: 1
Composition
Registration
- Registration number
- EMEA/H/C/000931
- Registration status
- Active
Sources
- product · EMA · EMEA/H/C/000931 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000931 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000931 · Verified 2026-10-09